09/08/2026
We are excited to announce that Source BioScience, the United Kingdom’s leading provider of histopathology services, is expanding its digital pathology operation powered by our HALO AP platform. Source BioScience has processed around 78,000 cases and 278,000 slides since implementing HALO AP at its Nottingham headquarters last October and is currently rolling out HALO AP at its Chichester laboratory site as the first stage in national expansion.
“We are proud to have selected HALO AP as our digital pathology platform," said Dr. Sinduh Menon, Deputy Medical Director for Source BioScience LDPath. "Its robust, scalable, and intuitive environment has enabled us to efficiently manage high-volume workflows while streamlining case review, enhancing collaboration, and providing reliable access to digital pathology data. The exceptional training and ongoing support from the HALO AP team were instrumental in ensuring a smooth implementation and successful adoption across our organization.”
Read the press release to learn more about HALO AP at Source BioScience and how the deployment is helping shorten turnaround times while improving traceability, compliance, and long-term image retention: https://indicalab.com/news/press-release/source-bioscience-selects-indica-labs-halo-ap-as-the-digital-pathology-platform-powering-the-future-of-nhs-outsourcing-in-the-united-kingdom/